Rayonier Adv. Materials

Rayonier Advanced Materials appointed Daniel Krawczyk as CEO and president and added him to the board while the company continues a review of strategic alternatives supported by Morgan Stanley. Krawczyk previously led Huber Engineered Materials, overseeing a $1.3bn business and more than $2bn of M&A and divestiture activity. The board dissolved the interim office of the CEO, returning interim members to their prior roles to work with Krawczyk as the firm evaluates options to maximize shareholder value. » More on finance.yahoo.com

CEO Scott Sutton unveiled a realignment focused on asset allocation and EBITDA improvement, aiming for positive free cash flow by 2026 and a doubling of EBITDA by 2028 versus 2025. The company is converting five business segments into 20 monetization channels and has raised prices on 88% of its business by 18%, but expects a 20% volume decline in cellulose specialties. Rayonier Advanced Materials plans a refinancing in 2027 to reduce interest costs; current debt is about $715 million. Operational programs like "RYAM Uplift" and a stronger emphasis on biomaterials are intended to boost efficiency, safety and growth. » More on de.investing.com

Rayonier Advanced Materials reported Q4 2025 EPS of -$0.32, missing the estimate of -$0.06, while revenue of $417 million beat expectations by 13.35%. The company recorded negative free cash flow of -$88 million for 2025 and is burdened by high‑interest debt. Management’s priority for 2026 is to achieve positive free cash flow and improve EBITDA, supported by strategic price increases in the cellulose specialties segment. After the results, the stock fell modestly in premarket trading as investors focused on the profitability issues. » More on de.investing.com